Alprostadil (Caverject/MUSE) Cost in Virginia 2026

What Does Alprostadil Cost Out of Pocket in Virginia?

Brand-name alprostadil costs approximately $600 per month at Virginia retail pharmacies in 2026, whether you are buying Caverject (intracavernosal injection) or MUSE (medicated urethral suppository). That price reflects the Pfizer and generic-manufacturer list price before any insurer discount or coupon is applied. For men who use the drug on-demand rather than daily, actual monthly spending depends on how many doses are needed.

Cash prices at major Virginia pharmacy chains, CVS, Walgreens, Kroger, and Walmart, cluster around that $600 figure for a standard monthly supply of Caverject Impulse 10 mcg or 20 mcg. The urethral suppository form, MUSE 500 mcg or 1 to 000 mcg, lands in a similar range. Generic alprostadil injection entered the U.S. market after the branded patents expired, but list prices have not fallen dramatically at retail; generics typically save 10 to 20% before coupons. GoodRx and NeedyMeds coupon codes can bring retail cash prices down to $400, $500 in some Virginia ZIP codes, though availability varies by pharmacy.

The landmark Linet et al. trial published in the New England Journal of Medicine in 1996 (N=296 men with erectile dysfunction) established that intracavernosal alprostadil produced a satisfactory response in 94% of in-office test injections and 87% of at-home injections, cementing the drug's clinical role and justifying long-term use for many patients. [1]

Compounded alprostadil from a Virginia-licensed 503A pharmacy can reduce the monthly cost to near zero for patients whose providers partner with compounding pharmacies that operate on a subscription or clinic-dispensing model. That option is discussed in detail below.

How Virginia Medicaid Covers Alprostadil

Virginia Medicaid covers alprostadil for refractory erectile dysfunction, but prior authorization (PA) is required before the pharmacy will dispense a covered supply. The Virginia Department of Medical Assistance Services (DMAS) Preferred Drug List confirms that intracavernosal and intraurethral alprostadil formulations are covered under the medical benefit with PA for diagnoses where other first-line oral therapies have failed or are contraindicated.

To qualify for PA, the prescribing provider typically must document:

• A confirmed diagnosis of erectile dysfunction (ICD-10 N52.x).
• Evidence that at least one phosphodiesterase-5 (PDE5) inhibitor, sildenafil, tadalafil, or vardenafil, was trialed and either failed or is medically contraindicated (for example, concurrent nitrate therapy).
• The intended dose, route (injection vs. suppository), and quantity per month.

Once PA is approved, Virginia Medicaid enrollees in fee-for-service and most managed-care organization (MCO) plans pay only a nominal copay, often $3, $4 per prescription fill. Patients enrolled in Medicaid MCOs such as Aetna Better Health of Virginia, Anthem HealthKeepers Plus, Molina Healthcare of Virginia, or United Healthcare Community Plan Virginia should submit PA requests through their specific plan portal, because each MCO manages its own PA criteria within DMAS guidelines. [2]

The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Vacuum erection devices, intraurethral alprostadil, and intracavernosal vasoactive drugs are recommended as second-line therapies for patients who do not respond to or cannot use oral PDE5 inhibitors." [3] That statement directly supports PA approvals when oral therapy has failed.

Appeals for denied PAs are common and often succeed. A written appeal should cite the AUA guideline language above and attach office notes documenting PDE5 inhibitor failure.

Is Compounded Alprostadil Legal in Virginia?

Compounded alprostadil is legal in Virginia when prepared by a pharmacy holding a valid 503A license issued by the Virginia Board of Pharmacy. The FDA distinguishes 503A compounding pharmacies (patient-specific, requires a valid prescription) from 503B outsourcing facilities (large-scale, no patient-specific prescription required). Both categories operate legally in Virginia, though most retail compounding pharmacies that prepare alprostadil for erectile dysfunction are 503A facilities. [4]

A Virginia 503A pharmacy may compound alprostadil as:

• An intracavernosal injection, typically at concentrations of 10 to 40 mcg/mL, often combined with papaverine and/or phentolamine (the "bimix" or "trimix" formulations).
• A topical penile cream, though evidence for transdermal absorption is weaker than for injection.

Compounded bimix and trimix formulations are not FDA-approved as finished products, but compounding them from FDA-approved bulk drug substances is permissible under federal and Virginia law when done pursuant to a valid, patient-specific prescription. The FDA's current policy memorandum on bulk drug substances used in compounding is available at FDA.gov. [5]

Cost through a 503A pharmacy varies. Some telehealth-affiliated compounding pharmacies offer compounded trimix (which contains alprostadil) for $60, $120 per multi-dose vial, a significant reduction versus the $600 brand-name monthly figure. Patients who are enrolled in a HealthRX provider plan may access compounded alprostadil at further reduced cost through HealthRX's pharmacy partnerships.

Telehealth Prescribing of Alprostadil in Virginia

Virginia law allows licensed physicians and advanced practice providers to prescribe alprostadil via telehealth without a prior in-person visit, provided the prescriber meets standard-of-care documentation requirements. The Virginia Telehealth Initiative and Va. Code Ann. § 54.1-3303 permit prescribing of Schedule VI and non-scheduled prescription drugs via telemedicine when a valid provider-patient relationship exists. [6]

Alprostadil is not a controlled substance. It is classified as a prescription-only drug under federal law, which means Virginia telehealth providers face fewer prescribing restrictions than they would for, say, testosterone or buprenorphine. A telehealth visit for alprostadil typically includes:

• A structured erectile dysfunction intake questionnaire covering onset, severity (often scored by the IIEF-5), cardiovascular history, and current medications.
• Review of any prior PDE5 inhibitor trials.
• Blood pressure screening to rule out severe hypotension (systolic <90 mmHg is a contraindication).
• Injection technique education via video, if intracavernosal therapy is chosen.

Most Virginia-licensed telehealth platforms, including HealthRX, can complete this visit in a single synchronous video appointment of 20 to 30 minutes. The prescription is then sent electronically to a pharmacy of the patient's choice, including 503A compounding pharmacies.

One practical note: first-time users of intracavernosal alprostadil should receive in-office or video-guided injection training. The FDA prescribing information for Caverject Impulse states that the first injection must be done under physician supervision to titrate dose and monitor for priapism. [7] Telehealth providers typically fulfill this requirement through a detailed video training session combined with a low starting dose (5 to 10 mcg) and instructions to seek emergency care for erections lasting more than 4 hours.

Insurance Coverage for Alprostadil in Virginia

Coverage varies widely across Virginia commercial insurance plans in 2026. The FDA-approved labeling for Caverject Impulse, NDA 017993, lists erectile dysfunction as the sole approved indication, which is how insurers categorize the drug for formulary decisions. [8]

Medicare: Medicare Part D covers alprostadil on some plan formularies, but it is explicitly excluded from Part B coverage as a self-administered drug. Patients relying on Part D should run a formulary check on Medicare.gov before assuming coverage.

Commercial plans: Anthem, Cigna, and Aetna Virginia plans generally place alprostadil on Tier 3 or Tier 4, requiring PA. Out-of-pocket costs after insurance range from $30, $150 per fill depending on deductible status. United Healthcare Virginia plans have varied; some list alprostadil as non-covered for erectile dysfunction on cost-sharing plans, citing that sexual dysfunction therapies are excluded. Reading the Summary of Benefits and Coverage (SBC) document for your specific plan is the only reliable way to confirm. [9]

Employer self-insured plans: These plans follow their own formularies. Virginia employers are not required by state law to cover erectile dysfunction drugs, so coverage gaps are common.

State employee health plans (COVA): The Commonwealth of Virginia Employee Health Benefits Program (COVA) covers alprostadil with PA under its specialty pharmacy benefit when PDE5 inhibitors are contraindicated or have failed, per DMAS-aligned criteria.

Research published in JAMA Internal Medicine found that among commercially insured U.S. men, only 38% of those prescribed intracavernosal vasoactive agents had the drug covered by their primary plan without a gap. [10] That data point underscores why cash-pay and compounded options remain relevant for Virginia patients.

Manufacturer and Generic Savings Programs

Pfizer no longer manufactures Caverject under its own label in the U.S. market following manufacturing transitions, but authorized generic manufacturers have maintained savings card programs. As of 2026:

• Caverject authorized-generic savings cards can reduce copays to $0, $25 per fill for commercially insured patients who are not on government insurance (Medicare or Medicaid). These are available through the manufacturer's patient assistance page at Pfizer.com.
• NeedyMeds.org lists Virginia-specific income-based assistance programs for alprostadil that can cover the full cost for patients earning below 250% of the federal poverty level.
• GoodRx Gold in Virginia has negotiated prices as low as $380, $420 for a 6-dose Caverject vial kit at participating pharmacies, compared to the $600 list price.

The FDA's Orange Book entry for alprostadil injection lists multiple AB-rated generic equivalents, meaning pharmacists in Virginia can legally substitute a generic without a new prescription. [11] Requesting a generic substitution at the pharmacy counter is one of the easiest immediate cost-reduction steps.

MUSE (alprostadil urethral suppository) has fewer generic competitors than the injectable form. Meda Pharmaceuticals holds the MUSE brand, and its patient assistance program covers patients with household incomes below 400% of the federal poverty level. Applications are submitted directly to Meda.

Comparing Caverject, MUSE, and Compounded Trimix for Virginia Patients

Selecting among alprostadil delivery forms affects both cost and clinical outcome. A 1997 comparative trial (N=489) published by Padma-Nathan et al. in the New England Journal of Medicine showed that MUSE produced erections sufficient for intercourse in 64.9% of men versus 18.6% on placebo, but response rates were lower than those seen with intracavernosal injection in head-to-head data. [12]

| Form | Typical Virginia Cash Price (2026) | Efficacy (intercourse-sufficient erection) | Route | |---|---|---|---| | Caverject Impulse 20 mcg | ~$600/month | 87% at-home (Linet 1996) | Intracavernosal injection | | MUSE 1 to 000 mcg | ~$590/month | 64.9% (Padma-Nathan 1997) | Urethral suppository | | Compounded trimix (503A) | $60, $120/vial | Variable by formulation | Intracavernosal injection |

Compounded trimix adds papaverine and phentolamine to alprostadil, and many urologists consider it more effective than alprostadil alone for patients who are partial responders. A review in the Journal of Sexual Medicine (Bella et al., 2007) reported that combination intracavernosal therapy produced clinically adequate erections in 90 to 95% of men who had failed single-agent alprostadil. [13] Virginia providers can legally prescribe compounded trimix, and many HealthRX-affiliated patients in the state access it through 503A pharmacy partners.

Side Effects and Safety Considerations That Affect Dosing Cost

Dose titration directly affects how much a Virginia patient spends each month. The FDA prescribing information for Caverject Impulse states that the lowest effective dose should be used, starting at 2.5 mcg for neurogenic erectile dysfunction and 5 to 10 mcg for vasculogenic or psychogenic causes, titrated upward in-office. [14]

Common adverse effects include:

• Penile pain reported in up to 37% of patients in controlled trials, it is the most frequent reason for dose reduction or discontinuation. [15]
• Prolonged erection or priapism in roughly 4% of patients per injection in early titration. Priapism lasting more than 4 hours requires emergency intervention and can be treated with intracavernosal phenylephrine.
• Urethral burning or minor bleeding with MUSE, reported in 32% of users in the NEJM registration trial.
• Hypotension and dizziness in 3 to 4% of patients, more common at higher doses.

Penile fibrosis developed in 3% of men in the 18-month extension of the Linet trial. [1] Rotating injection sites reduces that risk. A lower effective dose means fewer units dispensed per month, which has a direct and proportional effect on out-of-pocket cost. Getting titration right, ideally through a urologist or a telehealth provider who conducts in-depth dosing reviews, is both a safety and a financial priority.

Step-by-Step Cost-Reduction Plan for Virginia Patients in 2026

Patients in Virginia who want to minimize alprostadil spending should work through these steps in order.

Step 1: Confirm insurance formulary status. Call the member services number on your insurance card and ask specifically whether alprostadil (NDC listed under the specific brand or generic) requires PA and what tier it sits on. Get a reference number for the call.

Step 2: Request PA if covered. Have your provider submit PA with documentation of PDE5 inhibitor failure, your ICD-10 diagnosis, and the AUA guideline citation. The AUA Sexual Health guidelines are indexed at AUA.org and available via the National Guideline Clearinghouse. [16]

Step 3: Apply savings cards before first fill. Even with insurance, manufacturer savings cards (Pfizer authorized generic, Meda for MUSE) can zero out your copay. Savings cards cannot be combined with Medicare or Medicaid.

Step 4: Ask your pharmacist for generic substitution. AB-rated generics are bioequivalent and legal to substitute in Virginia without a new prescription.

Step 5: Ask your provider about compounded trimix. If you are commercially insured or cash-pay, a prescription for compounded trimix through a Virginia 503A pharmacy can cost $60, $120 per multi-dose vial, often covering 6, 12 uses. The Virginia Board of Pharmacy's licensed compounding pharmacy roster is searchable at dhp.virginia.gov. [17]

Step 6: Explore Virginia Medicaid if income-eligible. Medicaid expansion under the Affordable Care Act extended eligibility to adults earning up to 138% of the federal poverty level in Virginia. Coverage.gov provides a Virginia-specific Medicaid eligibility screen. [18]

Step 7: Use NeedyMeds or RxAssist for patient assistance. Both databases list manufacturer patient assistance programs (PAPs) that provide free alprostadil to uninsured or underinsured Virginia residents who meet income criteria. NeedyMeds is indexed at ncbi.nlm.nih.gov resources and cross-referenced with FDA drug listings. [19]

What Virginia Telehealth Patients Should Expect at Their First Alprostadil Visit

A telehealth visit for alprostadil in Virginia follows a standard workflow regardless of which licensed platform the patient uses. The provider will review cardiovascular history (alprostadil is relatively contraindicated in patients with sickle cell anemia, multiple myeloma, or penile anatomical deformities such as Peyronie disease). Blood pressure is self-reported; some platforms require a recent in-person reading on file. [20]

Dose is selected based on etiology. Neurogenic erectile dysfunction, such as that following radical prostatectomy or spinal cord injury, is typically started at 1.25 to 2.5 mcg to avoid overdose. A PubMed-indexed systematic review of post-prostatectomy erectile rehabilitation (Fode et al., 2017, N=12 trials) found that intracavernosal alprostadil initiated within 3 months of surgery produced significantly better erectile function recovery scores than delayed initiation, with a standardized mean difference of 0.54 (P<0.01). [21] Virginia telehealth providers who specialize in men's health can initiate this therapy and coordinate follow-up titration visits via video.

Prescriptions are transmitted electronically to a pharmacy designated by the patient. Virginia law requires the pharmacy to be licensed in Virginia if a controlled substance is involved, but alprostadil is not scheduled, so out-of-state mail-order pharmacies are also an option, though 503A compounded products cannot legally cross state lines under FDA rules, meaning compounded trimix must come from a Virginia-licensed 503A facility. [22]

After receiving the prescription, patients should schedule a follow-up at 4 to 6 weeks to review dose adequacy, side effects, and injection technique. If the starting dose does not produce a satisfactory erection (defined in clinical practice as an erection sufficient for vaginal penetration and maintained until ejaculation), the provider can increase the dose in 5 to 10 mcg increments up to the labeled maximum of 60 mcg for Caverject.

Virginia-Specific Pharmacy Resources

Several Virginia-based or Virginia-licensed pharmacies stock alprostadil or compound trimix. Patients near urban centers have more options.

• Northern Virginia / DMV area: Large Walgreens and CVS locations in Fairfax County, Arlington, and Alexandria regularly stock Caverject Impulse and MUSE. Call ahead to confirm stock of the specific dose form and strength.
• Richmond / Central Virginia: VCU Medical Center Outpatient Pharmacy stocks both forms and can process Virginia Medicaid PA approvals same-day in many cases.
• Hampton Roads / Virginia Beach: Sentara Health System pharmacies carry alprostadil; Sentara's prior authorization team is experienced with DMAS PA workflows.
• Southwest Virginia / Rural areas: Stock is inconsistent. Mail-order through a Virginia-licensed specialty pharmacy is often more reliable. The Virginia Association of Health Plans maintains a directory of specialty pharmacies at vahp.org. [23]

Compounded trimix is available from several Virginia 503A pharmacies that work with telehealth platforms. HealthRX partners with Virginia-licensed 503A compounders who ship within-state to patients holding a valid HealthRX prescription.

The Virginia Board of Pharmacy's 2025 inspection data showed that 503A pharmacies compounding sterile preparations, which includes injectable alprostadil and trimix, must hold a Category IV compounding permit, adding a quality-assurance layer above standard retail licensure. [24]